CTOs on the Move

Aspen Neuroscience

www.aspenneuroscience.com

 
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson`s disease (PD) and extending across the brain and affected organs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kim Raineri
 Chief Technology Officer Profile

Funding

Aspen Neuroscience raised $70M on 04/01/2020
Aspen Neuroscience raised $147.5M on 05/09/2022

Similar Companies

Innovate Biopharmaceuticals

Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological disorders.

StemoniX

StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity.

Affinia Therapeutics

We are working to methodically engineer durable gene therapies for people with devastating diseases.

Lynxcom Partners

Lynxcom Partners is a Del Mar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telik

Telik is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.